STOCKHOLM, May 4, 2021 / PRNewswire / – RaySearch Laboratories AB (publ) announces the establishment of a wholly owned subsidiary based in Australia to serve the Australia and New Zealand markets. RaySearch Australia and New Zealand will provide direct service and sales to customers in the region.
By establishing a strong local presence, RaySearch will be better able to meet the needs of customers in Australasia, which is a stable and growing market for advanced oncology software.
RaySearch already has a strong market presence in Australasia and several leading clinics in the region have chosen RayStation® * as their treatment planning system. Until now, the company’s operations in the region have been managed through an agreement with local distributor alphaXRT. The two companies will maintain a close collaboration to ensure the best possible service to customers in the future.
RaySearch Australia and New Zealand will be led by Meshan Naidu, which was previously located at RaySearch headquarters in Sweden, where he held the position of Global Service IT Manager.
Meshan Naidu, Regional Sales Manager, RaySearch Australia: “We look forward to building strong relationships with clinics in Australia and New Zealand and provide the highest level of service and support to our customers. ”
Johan Löf, CEO of RaySearch, said: “The creation of RaySearch Australia and New Zealand marks an important step forward for our presence in Australasia. We are committed to meeting the needs of clients in the region and look forward to partnering with other forward thinking clinics. “
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets its RayStation treatment planning system and next-generation oncology information system RayCare * worldwide. Over 2,600 clinics in over 65 countries use RaySearch software to improve patient lives and outcomes. The company was founded in 2000 and the stock has been listed on Nasdaq Stockholm since 2003.
RayStation is a flexible and innovative treatment planning system chosen by many of the world’s leading cancer centers. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, state-of-the-art algorithms for IMRT and VMAT optimization with highly precise dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of processing machines, providing a control center for all processing planning needs and ensuring that centers get more value from existing equipment. RayStation also integrates seamlessly with RayCare, the next generation oncology information system. By aligning treatment planning, we are enabling better care for cancer patients around the world.
* Subject to regulatory approval in certain markets.
More information about RaySearch is available at www.raysearchlabs.com
For more information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8-510 530 00
Peter Thysell, Chief Financial Officer, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 70 661 05 59
This information was provided to you by Cision http://news.cision.com
The following files are available for download:
SOURCE RaySearch Laboratories